Fampyra - Model 10 mg - Prolonged Release Tablets
From European Union - EU Products Using Alkermes Technologies
Fampyra 10 mg prolonged-release tablets. The recommended dose is one 10 mg tablet, twice daily, taken 12 hours apart (one tablet in the morning and one tablet in the evening). Fampyra should not be administered more frequently or at higher doses than recommended (see section 4.4). The tablets should be taken without food (see section 5.2).
Product Details
If decline in walking ability is observed, physicians should consider an interruption to treatment in order to reassess the benefits of Fampyra (see above). The re-evaluation should include withdrawal of Fampyra and performing an assessment of walking ability. Fampyra should be discontinued if patients no longer receive walking benefit
Customer reviews
No reviews were found for Fampyra - Model 10 mg - Prolonged Release Tablets. Be the first to review!